Overview
- 48 inspections across 44 sites are on record.
- 164 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2022-08-30.
At a glance
Inspections
48
Sites
44
Observations
164
Career since
Jan 2016
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Bora Pharmaceuticals Inc. | 30 Aug 2022 | Human Drugs | On file |
| Akorn, Inc. | 8 Apr 2022 | Human Drugs | On file |
| Padagis US LLC | 18 Feb 2022 | Human Drugs | On file |
| Mclaughlin Gormley King Company | 8 Dec 2021 | Human Drugs | On file |
| Surmodics Inc | 19 Oct 2021 | Medical Devices & Rad Health |
Sites inspected
Bora Pharmaceuticals Inc.Maple Grove, United States1 insp.
Akorn, Inc.Decatur, United States1 insp.
Padagis US LLCMinneapolis, United States1 insp.
Mclaughlin Gormley King CompanyChaska, United States1 insp.
Surmodics IncEden Prairie, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Scott A Golladay10 shared
Anthony J Ladner6 shared
Courtney R Ingalsbe5 shared
Kevin P Regan4 shared
Courtney R Tiegs3 shared
Karen M Labounty3 shared
Ralph W Jerndal2 shared
Andrew J Idzior2 shared
James K Ireland2 shared
Matthew B Casale2 shared
Full investigator report
Get the verbatim findings behind Ross J Grigsby's 164 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site